rs199473391
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP2PP3_Moderate
The NM_000719.7(CACNA1C):c.3343G>A(p.Glu1115Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E1115G) has been classified as Uncertain significance.
Frequency
Consequence
NM_000719.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.3343G>A | p.Glu1115Lys | missense_variant | 26/47 | ENST00000399655.6 | |
CACNA1C | NM_001167623.2 | c.3343G>A | p.Glu1115Lys | missense_variant | 26/47 | ENST00000399603.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.3343G>A | p.Glu1115Lys | missense_variant | 26/47 | 5 | NM_001167623.2 | ||
CACNA1C | ENST00000399655.6 | c.3343G>A | p.Glu1115Lys | missense_variant | 26/47 | 1 | NM_000719.7 | ||
CACNA1C-AS3 | ENST00000543559.1 | n.20+304C>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes ? Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome ? Cov.: 33
ClinVar
Submissions by phenotype
Timothy syndrome Pathogenic:1Other:1
not provided, no classification provided | literature only | GeneReviews | - | Brugada syndrome - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 29, 2022 | - - |
Timothy syndrome;C2678478:Brugada syndrome 3;CN260585:Long qt syndrome 8 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 20, 2022 | - - |
Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Sep 19, 2019 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has been reported to affect CACNA1C protein function (PMID: 30172029). This variant has been observed in individuals with Brugada syndrome and individuals with long QT syndrome (LQTS) (PMID: 20817017, 30662450, 30172029, Invitae). ClinVar contains an entry for this variant (Variation ID: 67554). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamic acid with lysine at codon 1115 of the CACNA1C protein (p.Glu1115Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. - |
Brugada syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Brugada syndrome in the following publications (PMID:20817017). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at